How do I know if tirzepatide will work for me: 7 factors
An analysis of four studies conducted by Eli Lilly, the maker of Mounjaro and Zepbound, found seven factors that were significantly linked with ≥15% weight loss when taking their blockbuster medications. According to this Medscape overview, Investigators conducted a post hoc analysis of data collected from a total of 3188 people with type 2 diabetes […]
Ozempic, Wegovy (semaglutide) vs Mounjaro, Zepbound (tirzepatide)
Background Wegovy and Zepbound are both approved for weight loss but started as medications for type 2 diabetes. Wegovy was originally approved under the name Ozempic in 2017, followed by Wegovy in 2021 for weight loss. Ozempic and Wegovy both contain the active ingredient semaglutide, a GLP-1 receptor agonist that helps with weight loss via […]
Oral semaglutide for weight loss
You’ve heard amazing testimonials online and on social media regarding weight loss on Ozempic, Wegovy and Mounjaro. These medications contain the active ingredient semaglutide in the case of Ozempic and Wegovy, or tirzepatide in the case of Mounjaro. These are weekly injections. As soon as some patients hear these are injections (albeit with small needles), […]
Much ado about nothing? Recent FDA alerts and NovoNordisk lawsuits
Due to the blockbuster weight loss drugs Ozempic, Wegovy and Mounjaro going on the FDA Shortage List, compounding pharmacies are legally allowed to make duplicates of these name brand drugs without risk of patent infringement. And even though NovoNordisk, the maker of Ozempic and Wegovy, admits they can’t keep up with demand, they’re trying everything […]
Shame on you Mississippi and West Virginia
Why would Mississippi and West Virginia, states that are ranked #1 and #4 in poverty, #5 and #1 in adult obesity, and #2 and #4 in adolescent obesity, respectively, eliminate access to the most affordable version of the safe and effective weight loss drugs Ozempic and Wegovy? Background on Ozempic and Wegovy Not since […]
Consumers’ misguided focus on the risks surrounding Ozempic and Wegovy
Consumers reluctant to try new weight loss drugs seem to focus more on the least likely risks such as pancreatitis and a rare type of thyroid cancer rather than focusing on the more common side effects like burping, nausea, vomiting, constipation and diarrhea. Instead of focusing on the risks associated with taking the medication, patients […]
Weight Management Webinar Series for Providers
1. Basics of a Weight Mngmt Program – Recording below We’re kicking off this series of 20-minute webinars on weight management programs by going over the basics. Learn how Dr. Jonathan Kaplan created and automated a program that allowed his practice to scale to over 300 patients, producing monthly recurring revenue of $140,000+. He’ll review: Needed […]
Automating your weight management (or any recurring subscription) program
Recently, our office posted a video on TikTok weighing in on whether a celebrity lost weight by diet, exercise and/or the use of the groundbreaking weight loss medication, semaglutide, the active ingredient in Ozempic (approved for type 2 diabetes in 2017) and Wegovy (approved for obesity in 2021) . It was a topic that our […]
10 Reasons Every Practice Should Add a Weight Management Program
1. Increase your patient base: Adding a weight management program to an aesthetic practice can help attract a new population of patients who are looking to improve their appearance and health through weight management. If your current practice offers weight loss surgery, then you already realize not every potential patient is a good candidate right […]
Overview of the Texas Medical Association Lawsuits over the No Surprises Act
Since implementation of the No Surprises Act (NSA) on January 1st, 2022, there have been four lawsuits brought on by the Texas Medical Association (TMA). Interesting that the TMA is more vocal and active legally and supportive of physicians in America than the American Medical Association (AMA). Not sure why anyone would pay dues to […]